Completed Spinoffs

Filter by: Upcoming | Completed

  Spinoff Name Spinoff Symbol Announced Date Spinoff Date First Day Closing Spinoff Last Price Spinoff Performance Spinoff Current Volume Parent Name Parent Symbol Parent First Day Closing Parent Last Price Parent Performace Parent Current Volume Type
Warner Bros. Discovery WBD 05/17/2021 04/08/2022 24.78 17.5 -29.38% 15,939,390 AT&T Inc. T 19.35 20.21 4.44% 41,182,332 Reverse Morris Trust
AT&T Inc., spinoff details:

May 17, 2021: AT&T Inc. (T) and Discovery, Inc. (DISCA, DISCB, DISCK) announced a definitive agreement to combine WarnerMedia’s premium entertainment, sports and news assets with Discovery’s leading nonfiction and international entertainment and sports businesses to create a premier, standalone global entertainment company.

Investor Presentation

Update(s):

June 1, 2021: Discovery, Inc. (DISCADISCBDISCK)  announced the new name of the proposed standalone global entertainment company that will emerge from the combination of WarnerMedia and Discovery assets: "Warner Bros. Discovery." 

June 23, 2021: EA Will Acquire Playdemic for $1.4 Billion in Cash.The remaining Warner Bros. Games portfolio is included in the recently announced WarnerMedia-Discovery transaction and will become part of the combined media and entertainment company after the expected close of that transaction. 

August 10, 2021: The company recently completed its DIRECTV transaction with TPG Capital and is moving forward with its plans to spin or split off WarnerMedia and combine it with Discovery to form a new entertainment company, Warner Bros. Discovery.

September 14, 2021: AT&T (T) continues to anticipate that its pending WarnerMedia-Discovery transaction will close by mid-2022

November 17, 2021: With regard to its pending WarnerMedia transaction with Discovery, the company continues to expect the transaction to close by mid-2022.

While dividend decisions are made at the discretion of the AT&T board of directors, Desroches said that after the transaction closes, AT&T expects an annual dividend payout ratio of 40% to 43% on anticipated free cash flows of $20 billion plus, equating to $8 billion to $9 billion in dividends annually.

December 6, 2021: Regarding the pending WarnerMedia-Discovery transaction, Stankey said the regulatory review process is proceeding as expected. Stankey reiterated expectations of leverage levels of 2.6x at the close of the deal and 2.5x by yearend 2023. 

February 1, 2022: AT&T Inc (T) said it will spin off WarnerMedia in a $43 billion transaction to merge its media properties with Discovery Inc (DISCA) and also cut its dividend by nearly half.

AT&T shareholders will own 71% of the new Warner Bros. Discovery company and will receive a 0.24 shares of Warner Bros. Discovery for each AT&T share they own. AT&T will have 7.2 billion diluted shares outstanding after the transaction closes.

February 1, 2022: The transaction, which will spin off 100% of AT&T’s interest in WarnerMedia to AT&T’s existing shareholders in a pro rata distribution, followed by the merger of WarnerMedia with Discovery, is expected to close in the second quarter of 2022.

On the closing date of the transaction, each AT&T shareholder will receive, on a tax-free basis, an estimated 0.24 shares of the new WBD common stock for each share of AT&T common stock held as of the record date for the pro rata distribution.

March 11, 2022: Discovery Inc (DISCAshareholders voted to approve the media company's $43 billion merger with WarnerMedia, moving the deal one step closer to completion.

March 25, 2022:

 AT&T Inc.* (T) announced that it has declared a stock dividend to effect the spin-off of 100% of AT&T’s interest in WarnerMedia to AT&T’s shareholders. The record date for the stock dividend is the close of business on April 5, 2022. 
 
 On the closing date of the transaction, anticipated to be in April, AT&T shareholders will receive, on a tax-free basis, an estimated 0.24 shares of stock in Warner Bros. Discovery, Inc. (WBD) for each share of AT&T common stock.

 AT&T Inc. (T) announced that it has declared a stock dividend to effect the spin-off of 100% of AT&T’s interest in WarnerMedia to AT&T’s shareholders. The record date for the stock dividend is the close of business on April 5, 2022.   On the closing date of the transaction, anticipated to be in April, AT&T shareholders will receive, on a tax-free basis, an estimated 0.24 shares of stock in Warner Bros. Discovery, Inc. (WBD) for each share of AT&T common stock.

April 8, 2022: Discovery, Inc. and AT&T Inc.* (Tannounced that they have closed their transaction to combine the WarnerMedia business with Discovery. The combination creates a premier standalone global media and entertainment company, Warner Bros. Discovery, Inc., which will begin trading on the Nasdaq with the start of trading on April 11, under the new ticker symbol “WBD.”

ESAB Corporation ESAB 03/04/2021 04/05/2022 45.05 46.79 3.86% 319,220 Enovis Corporation (Previously Colfax Corporation) ENOV 70.45 66.27 -5.93% 270,472 Splitoff
Enovis Corporation (Previously Colfax Corporation), spinoff details:

March 4, 2021: Colfax Corporation (CFX), a leading diversified technology company, today announced its intention to separate its fabrication technology and specialty medical technology businesses into two differentiated, independent, and publicly-traded companies. The separation is intended to be structured in a tax-free manner and is targeted to be completed in the first quarter of 2022.

Investor Presentation

Update(s):

November 04, 2021: The Company is making meaningful progress on its expected tax-free spin-off of its ESAB business to Colfax shareholders in the form of a dividend in the first quarter of 2022. Colfax Corporation (CFX) announced that it will transition to its new name, Enovis, at the time of the separation.

February 22, 2022: Colfax (CFXintends to distribute 90% of the outstanding shares in ESAB to Colfax shareholders on a pro rata basis in a distribution intended to be tax-free to Colfax. The Company plans to divest its 10% retained shares in ESAB within 12 months after the spin-off in a tax-efficient exchange for its outstanding debt.

March 11, 2022: Colfax Corporation (CFX), announced the future composition of the Board of Directors of the Company, which will be renamed Enovis Corporation upon the consummation of the Company’s previously announced spin-off of its existing fabrication technology business, which will operate as ESAB Corporation.

March 14, 2022: Colfax (CFX) Announces Expected Completion Date of April 4, 2022 for Spin-Off of ESAB Corporation

Upon completion of the distribution, Colfax will effect the Reverse Stock Split and change its name to Enovis Corporation (“Enovis”). Following the distribution, Enovis will trade on the NYSE under the symbol “ENOV.”

March 28, 2022: Colfax (CFX) Announces Board of Directors for Post-Spinoff ESAB. Following the Separation, Mitchell P. Rales will serve as chairman of the Board, and current Colfax directors Patrick W. Allender, Rhonda L. Jordan, Didier Teirlinck and Rajiv Vinnakota will serve as directors of ESAB. 

April 5, 2022:

Enovis Corporation (ENOV), formerly known as Colfax Corporation, announced  the completion of its previously announced separationof its fabrication technology business into an independent, publicly traded company, ESAB Corporation (ESAB). 
Immediately following the Separation, Enovis effected its previously announced reverse stock split of all issued and outstanding shares of Enovis common stock at a one-for-three ratio.

Enovis Corporation (ENOV), formerly known as Colfax Corporation, announced the completion of its previously announced separation of its fabrication technology business into an independent, publicly traded company, ESAB Corporation (ESAB). 

Immediately following the Separation, Enovis effected its previously announced reverse stock split of all issued and outstanding shares of Enovis common stock at a one-for-three ratio.

embecta EMBC 05/06/2021 04/01/2022 30.50 27.18 -10.89% 648,412 Becton, Dickinson and Company BDX 262.50 251.14 -4.33% 1,132,463 Spinoff
Becton, Dickinson and Company, spinoff details:

May 06, 2021: BD (Becton, Dickinson and Company) (BDX), a leading global medical technology company, announced its board of directors has unanimously authorized management to proceed with a plan to spin off the company's Diabetes Care business as an independent, publicly-traded company ("NewCo").

Form 10-12B

Investor Presentation

Update(s):

July 12, 2021: BD (Becton, Dickinson and Company) (BDX), announced that David F. Melcher will be non-executive chair of the board of directors, and Claire Pomeroy, MD, MBA, will be a director of the company formed in connection with the previously announced separation of the Diabetes Care business into an independent, publicly traded company ("NewCo").

December 6, 2021: BD (Becton, Dickinson and Company) (BDX),  announced that "embecta" will be the name of the independent, publicly-traded company that will hold BD's Diabetes Care business upon the completion of the previously announced spinoff, which is expected to close in the second quarter of calendar year 2022.

December 21, 2021: BD (Becton, Dickinson, and Company) (BDX), announced that Embecta Corp., the independent, publicly-traded company that will hold BD's Diabetes Care business upon the planned completion of the previously announced spinoff, will be governed by a nine-person board of directors.

February 23, 2022: BD (Becton, Dickinson and Company) (BDX),  announced that embecta, the diabetes care business that is expected to spin off from BD on April 1, 2022, will host a virtual Investor Event on March 7, 2022.

March 21, 2022: Record date for spin-off is March 22, 2022. BD expects the spin-off of embecta to be completed on April 1, 2022. "Regular way" trading of embecta common shares is expected to commence on April 1, 2022, under the ticker "EMBC"

April 1, 2022: BD (Becton, Dickinson and Company) (BDX), announced that it has completed its spinoff of Embecta Corp. (embecta) (EMBC), which holds BD's former Diabetes Care business and is now one of the largest pure-play diabetes management companies in the world.

ZimVie ZIMV 02/05/2021 03/01/2022 25.53 23.96 -6.15% 372,043 Zimmer Biomet Holdings, Inc. ZBH 124.14 116.91 -5.82% 765,557 Spinoff
Zimmer Biomet Holdings, Inc., spinoff details:

February 05, 2021: Zimmer Biomet Holdings, Inc. (ZBH), a global leader in musculoskeletal healthcare, today announced its intention to spin off the Company's Spine and Dental businesses to form a new and independent, publicly traded company ("NewCo").

Investor Presentation

Update(s):

February 16, 2021: Zimmer Biomet Holdings, Inc. (ZBH), announced that Vafa Jamali has been appointed as CEO of "NewCo", the independent, publicly traded company that will be created by a previously announced spin off transaction, expected to close in mid-2022. NewCo will be comprised of Zimmer Biomet's current Spine and Dental businesses.

September 14, 2021: Zimmer Biomet Holdings, Inc. (ZBH), announced key appointments to the "NewCo" leadership team, including Richard J. Heppenstall as Executive Vice President and Chief Financial Officer. Additionally, the Company announced ZimVie as the name for the planned spin-off company for the Spine and Dental businesses.

January 21, 2022: Zimmer Biomet Holdings, Inc. (ZBH) announced that it has filed a Form 10 registration statement with the United States Securities and Exchange Commission ("SEC") in connection with the intended spinoff of its Dental and Spine businesses into a standalone, publicly-traded company, ZimVie. In addition, ZimVie will host a virtual Investor Day on Monday, February 7, 2022

 

February 07, 2022: Zimmer Biomet Holdings, Inc. (ZBH)  announced that "Regular-way" trading of ZimVie common stock is expected to begin on NASDAQ on March 1, 2022, under the symbol "ZIMV." 
As a result of the dividend, Zimmer Biomet shareholders will receive one share of ZimVie common stock for every ten shares of Zimmer Biomet common stock they hold on the Record Date.  Immediately following the dividend, Zimmer Biomet will retain 19.7% of the outstanding shares of ZimVie common stock, which Zimmer Biomet intends to divest after the separation in a tax-efficient manner.

February 07, 2022: Zimmer Biomet Holdings, Inc. (ZBH)  announced that "Regular-way" trading of ZimVie common stock is expected to begin on NASDAQ on March 1, 2022, under the symbol "ZIMV." 

As a result of the dividend, Zimmer Biomet shareholders will receive one share of ZimVie common stock for every ten shares of Zimmer Biomet common stock they hold on the Record Date.  Immediately following the dividend, Zimmer Biomet will retain 19.7% of the outstanding shares of ZimVie common stock, which Zimmer Biomet intends to divest after the separation in a tax-efficient manner.

March 1, 2022: Zimmer Biomet Holdings, Inc. (ZBH), announced that the Company has completed its spinoff of ZimVie, Zimmer Biomet's former Dental and Spine business.  ZimVie shares will begin "regular way" trading on the Nasdaq today under the symbol "ZIMV."

Constellation Energy Corp. CEG 02/24/2021 02/02/2022 53.01 57.23 7.96% 2,038,902 Exelon Corp. EXC 42.86 47.35 10.48% 5,698,948 Splitoff
Exelon Corp., spinoff details:

February 24, 2021: Exelon Corp. (EXC) announced that its Board of Directors has approved a plan to separate Exelon Utilities (RemainCo), comprised of the company’s six regulated electric and gas utilities, and Exelon Generation (SpinCo), its competitive power generation and customer-facing energy businesses into two publicly traded companies with the resources necessary to best serve customers and sustain long-term investment and operating excellence. The separation gives each company the financial and strategic independence to focus on its specific customer needs, while executing its core business strategy.

Investor Presentation

Update(s):

October 1, 2021: Joseph Dominguez, currently CEO of ComEd, has been named CEO of the competitive energy business, which will be called Constellation.

November 17, 2021: Exelon Corp. (EXC) announced that the U.S. Nuclear Regulatory Commission (NRC) has approved the company’s plan to separate into two companies, Exelon and Constellation, in the first quarter of 2022. Exelon will separate its transmission and distribution utility business (Exelon) and its retail energy and competitive power generation business (Constellation), which includes the nation’s largest fleet of nuclear power plants.

December 08, 2021: Form 10-12B

December 16, 2021: Exelon Corp. (EXC) announced that the New York State Public Service Commission has approved a unanimous settlement agreement that allows Exelon to move forward with its plan to separate into two companies in the first quarter of 2022.

January 07, 2022: Exelon Corp. (EXC) announced Constellation’s Board of Directors following the company’s separation from Exelon. Constellation’s shares will begin trading February 2 under the ticker CEG.

February 2, 2022: Exelon Corp. (EXC) announced it has completed the separation of Constellation Energy Corp. Exelon’s transmission and distribution utility business will continue to be called Exelon and trade on Nasdaq under the ticker symbol "EXC." Constellation has begun “regular way” trading on the Nasdaq Global Select Market today under the symbol “CEG.”

Douglas Elliman Inc. DOUG 11/08/2021 12/30/2021 12.13 5.09 -58.04% 366,247 Vector Group Ltd VGR 11.30 11.63 2.92% 711,018 Spinoff
Vector Group Ltd, spinoff details:

November 08, 2021: Vector Group Ltd. (VGR) announced that Douglas Elliman Inc. plans to file a Form 10 registration statement with the United States Securities and Exchange Commission in connection with its intended spin-off into a standalone, publicly-traded company.

Investor presentation

November 10, 2021: Form 10-12B

December 10, 2021: Vector Group Ltd. (VGR) announced that its board of directors has approved the spin-off of Douglas Elliman Inc.  which is expected to be completed in late-December.

December 30, 2021: Vector Group Ltd. (VGR) has completed the spin-off of Douglas Elliman Inc. into a standalone, publicly traded company. Douglas Elliman’s common stock will begin “regular way” trading on the New York Stock Exchange on December 30, 2021 under the symbol “DOUG” and Vector Group will continue to trade on the NYSE under the symbol “VGR”.

  Spinoff Name Announced Date Parent Symbol
Warner Bros. Discovery 05/17/2021 T
AT&T Inc., spinoff details:

May 17, 2021: AT&T Inc. (T) and Discovery, Inc. (DISCA, DISCB, DISCK) announced a definitive agreement to combine WarnerMedia’s premium entertainment, sports and news assets with Discovery’s leading nonfiction and international entertainment and sports businesses to create a premier, standalone global entertainment company.

Investor Presentation

Update(s):

June 1, 2021: Discovery, Inc. (DISCADISCBDISCK)  announced the new name of the proposed standalone global entertainment company that will emerge from the combination of WarnerMedia and Discovery assets: "Warner Bros. Discovery." 

June 23, 2021: EA Will Acquire Playdemic for $1.4 Billion in Cash.The remaining Warner Bros. Games portfolio is included in the recently announced WarnerMedia-Discovery transaction and will become part of the combined media and entertainment company after the expected close of that transaction. 

August 10, 2021: The company recently completed its DIRECTV transaction with TPG Capital and is moving forward with its plans to spin or split off WarnerMedia and combine it with Discovery to form a new entertainment company, Warner Bros. Discovery.

September 14, 2021: AT&T (T) continues to anticipate that its pending WarnerMedia-Discovery transaction will close by mid-2022

November 17, 2021: With regard to its pending WarnerMedia transaction with Discovery, the company continues to expect the transaction to close by mid-2022.

While dividend decisions are made at the discretion of the AT&T board of directors, Desroches said that after the transaction closes, AT&T expects an annual dividend payout ratio of 40% to 43% on anticipated free cash flows of $20 billion plus, equating to $8 billion to $9 billion in dividends annually.

December 6, 2021: Regarding the pending WarnerMedia-Discovery transaction, Stankey said the regulatory review process is proceeding as expected. Stankey reiterated expectations of leverage levels of 2.6x at the close of the deal and 2.5x by yearend 2023. 

February 1, 2022: AT&T Inc (T) said it will spin off WarnerMedia in a $43 billion transaction to merge its media properties with Discovery Inc (DISCA) and also cut its dividend by nearly half.

AT&T shareholders will own 71% of the new Warner Bros. Discovery company and will receive a 0.24 shares of Warner Bros. Discovery for each AT&T share they own. AT&T will have 7.2 billion diluted shares outstanding after the transaction closes.

February 1, 2022: The transaction, which will spin off 100% of AT&T’s interest in WarnerMedia to AT&T’s existing shareholders in a pro rata distribution, followed by the merger of WarnerMedia with Discovery, is expected to close in the second quarter of 2022.

On the closing date of the transaction, each AT&T shareholder will receive, on a tax-free basis, an estimated 0.24 shares of the new WBD common stock for each share of AT&T common stock held as of the record date for the pro rata distribution.

March 11, 2022: Discovery Inc (DISCAshareholders voted to approve the media company's $43 billion merger with WarnerMedia, moving the deal one step closer to completion.

March 25, 2022:

 AT&T Inc.* (T) announced that it has declared a stock dividend to effect the spin-off of 100% of AT&T’s interest in WarnerMedia to AT&T’s shareholders. The record date for the stock dividend is the close of business on April 5, 2022. 
 
 On the closing date of the transaction, anticipated to be in April, AT&T shareholders will receive, on a tax-free basis, an estimated 0.24 shares of stock in Warner Bros. Discovery, Inc. (WBD) for each share of AT&T common stock.

 AT&T Inc. (T) announced that it has declared a stock dividend to effect the spin-off of 100% of AT&T’s interest in WarnerMedia to AT&T’s shareholders. The record date for the stock dividend is the close of business on April 5, 2022.   On the closing date of the transaction, anticipated to be in April, AT&T shareholders will receive, on a tax-free basis, an estimated 0.24 shares of stock in Warner Bros. Discovery, Inc. (WBD) for each share of AT&T common stock.

April 8, 2022: Discovery, Inc. and AT&T Inc.* (Tannounced that they have closed their transaction to combine the WarnerMedia business with Discovery. The combination creates a premier standalone global media and entertainment company, Warner Bros. Discovery, Inc., which will begin trading on the Nasdaq with the start of trading on April 11, under the new ticker symbol “WBD.”

ESAB Corporation 03/04/2021 ENOV
Enovis Corporation (Previously Colfax Corporation), spinoff details:

March 4, 2021: Colfax Corporation (CFX), a leading diversified technology company, today announced its intention to separate its fabrication technology and specialty medical technology businesses into two differentiated, independent, and publicly-traded companies. The separation is intended to be structured in a tax-free manner and is targeted to be completed in the first quarter of 2022.

Investor Presentation

Update(s):

November 04, 2021: The Company is making meaningful progress on its expected tax-free spin-off of its ESAB business to Colfax shareholders in the form of a dividend in the first quarter of 2022. Colfax Corporation (CFX) announced that it will transition to its new name, Enovis, at the time of the separation.

February 22, 2022: Colfax (CFXintends to distribute 90% of the outstanding shares in ESAB to Colfax shareholders on a pro rata basis in a distribution intended to be tax-free to Colfax. The Company plans to divest its 10% retained shares in ESAB within 12 months after the spin-off in a tax-efficient exchange for its outstanding debt.

March 11, 2022: Colfax Corporation (CFX), announced the future composition of the Board of Directors of the Company, which will be renamed Enovis Corporation upon the consummation of the Company’s previously announced spin-off of its existing fabrication technology business, which will operate as ESAB Corporation.

March 14, 2022: Colfax (CFX) Announces Expected Completion Date of April 4, 2022 for Spin-Off of ESAB Corporation

Upon completion of the distribution, Colfax will effect the Reverse Stock Split and change its name to Enovis Corporation (“Enovis”). Following the distribution, Enovis will trade on the NYSE under the symbol “ENOV.”

March 28, 2022: Colfax (CFX) Announces Board of Directors for Post-Spinoff ESAB. Following the Separation, Mitchell P. Rales will serve as chairman of the Board, and current Colfax directors Patrick W. Allender, Rhonda L. Jordan, Didier Teirlinck and Rajiv Vinnakota will serve as directors of ESAB. 

April 5, 2022:

Enovis Corporation (ENOV), formerly known as Colfax Corporation, announced  the completion of its previously announced separationof its fabrication technology business into an independent, publicly traded company, ESAB Corporation (ESAB). 
Immediately following the Separation, Enovis effected its previously announced reverse stock split of all issued and outstanding shares of Enovis common stock at a one-for-three ratio.

Enovis Corporation (ENOV), formerly known as Colfax Corporation, announced the completion of its previously announced separation of its fabrication technology business into an independent, publicly traded company, ESAB Corporation (ESAB). 

Immediately following the Separation, Enovis effected its previously announced reverse stock split of all issued and outstanding shares of Enovis common stock at a one-for-three ratio.

embecta 05/06/2021 BDX
Becton, Dickinson and Company, spinoff details:

May 06, 2021: BD (Becton, Dickinson and Company) (BDX), a leading global medical technology company, announced its board of directors has unanimously authorized management to proceed with a plan to spin off the company's Diabetes Care business as an independent, publicly-traded company ("NewCo").

Form 10-12B

Investor Presentation

Update(s):

July 12, 2021: BD (Becton, Dickinson and Company) (BDX), announced that David F. Melcher will be non-executive chair of the board of directors, and Claire Pomeroy, MD, MBA, will be a director of the company formed in connection with the previously announced separation of the Diabetes Care business into an independent, publicly traded company ("NewCo").

December 6, 2021: BD (Becton, Dickinson and Company) (BDX),  announced that "embecta" will be the name of the independent, publicly-traded company that will hold BD's Diabetes Care business upon the completion of the previously announced spinoff, which is expected to close in the second quarter of calendar year 2022.

December 21, 2021: BD (Becton, Dickinson, and Company) (BDX), announced that Embecta Corp., the independent, publicly-traded company that will hold BD's Diabetes Care business upon the planned completion of the previously announced spinoff, will be governed by a nine-person board of directors.

February 23, 2022: BD (Becton, Dickinson and Company) (BDX),  announced that embecta, the diabetes care business that is expected to spin off from BD on April 1, 2022, will host a virtual Investor Event on March 7, 2022.

March 21, 2022: Record date for spin-off is March 22, 2022. BD expects the spin-off of embecta to be completed on April 1, 2022. "Regular way" trading of embecta common shares is expected to commence on April 1, 2022, under the ticker "EMBC"

April 1, 2022: BD (Becton, Dickinson and Company) (BDX), announced that it has completed its spinoff of Embecta Corp. (embecta) (EMBC), which holds BD's former Diabetes Care business and is now one of the largest pure-play diabetes management companies in the world.

ZimVie 02/05/2021 ZBH
Zimmer Biomet Holdings, Inc., spinoff details:

February 05, 2021: Zimmer Biomet Holdings, Inc. (ZBH), a global leader in musculoskeletal healthcare, today announced its intention to spin off the Company's Spine and Dental businesses to form a new and independent, publicly traded company ("NewCo").

Investor Presentation

Update(s):

February 16, 2021: Zimmer Biomet Holdings, Inc. (ZBH), announced that Vafa Jamali has been appointed as CEO of "NewCo", the independent, publicly traded company that will be created by a previously announced spin off transaction, expected to close in mid-2022. NewCo will be comprised of Zimmer Biomet's current Spine and Dental businesses.

September 14, 2021: Zimmer Biomet Holdings, Inc. (ZBH), announced key appointments to the "NewCo" leadership team, including Richard J. Heppenstall as Executive Vice President and Chief Financial Officer. Additionally, the Company announced ZimVie as the name for the planned spin-off company for the Spine and Dental businesses.

January 21, 2022: Zimmer Biomet Holdings, Inc. (ZBH) announced that it has filed a Form 10 registration statement with the United States Securities and Exchange Commission ("SEC") in connection with the intended spinoff of its Dental and Spine businesses into a standalone, publicly-traded company, ZimVie. In addition, ZimVie will host a virtual Investor Day on Monday, February 7, 2022

 

February 07, 2022: Zimmer Biomet Holdings, Inc. (ZBH)  announced that "Regular-way" trading of ZimVie common stock is expected to begin on NASDAQ on March 1, 2022, under the symbol "ZIMV." 
As a result of the dividend, Zimmer Biomet shareholders will receive one share of ZimVie common stock for every ten shares of Zimmer Biomet common stock they hold on the Record Date.  Immediately following the dividend, Zimmer Biomet will retain 19.7% of the outstanding shares of ZimVie common stock, which Zimmer Biomet intends to divest after the separation in a tax-efficient manner.

February 07, 2022: Zimmer Biomet Holdings, Inc. (ZBH)  announced that "Regular-way" trading of ZimVie common stock is expected to begin on NASDAQ on March 1, 2022, under the symbol "ZIMV." 

As a result of the dividend, Zimmer Biomet shareholders will receive one share of ZimVie common stock for every ten shares of Zimmer Biomet common stock they hold on the Record Date.  Immediately following the dividend, Zimmer Biomet will retain 19.7% of the outstanding shares of ZimVie common stock, which Zimmer Biomet intends to divest after the separation in a tax-efficient manner.

March 1, 2022: Zimmer Biomet Holdings, Inc. (ZBH), announced that the Company has completed its spinoff of ZimVie, Zimmer Biomet's former Dental and Spine business.  ZimVie shares will begin "regular way" trading on the Nasdaq today under the symbol "ZIMV."

Constellation Energy Corp. 02/24/2021 EXC
Exelon Corp., spinoff details:

February 24, 2021: Exelon Corp. (EXC) announced that its Board of Directors has approved a plan to separate Exelon Utilities (RemainCo), comprised of the company’s six regulated electric and gas utilities, and Exelon Generation (SpinCo), its competitive power generation and customer-facing energy businesses into two publicly traded companies with the resources necessary to best serve customers and sustain long-term investment and operating excellence. The separation gives each company the financial and strategic independence to focus on its specific customer needs, while executing its core business strategy.

Investor Presentation

Update(s):

October 1, 2021: Joseph Dominguez, currently CEO of ComEd, has been named CEO of the competitive energy business, which will be called Constellation.

November 17, 2021: Exelon Corp. (EXC) announced that the U.S. Nuclear Regulatory Commission (NRC) has approved the company’s plan to separate into two companies, Exelon and Constellation, in the first quarter of 2022. Exelon will separate its transmission and distribution utility business (Exelon) and its retail energy and competitive power generation business (Constellation), which includes the nation’s largest fleet of nuclear power plants.

December 08, 2021: Form 10-12B

December 16, 2021: Exelon Corp. (EXC) announced that the New York State Public Service Commission has approved a unanimous settlement agreement that allows Exelon to move forward with its plan to separate into two companies in the first quarter of 2022.

January 07, 2022: Exelon Corp. (EXC) announced Constellation’s Board of Directors following the company’s separation from Exelon. Constellation’s shares will begin trading February 2 under the ticker CEG.

February 2, 2022: Exelon Corp. (EXC) announced it has completed the separation of Constellation Energy Corp. Exelon’s transmission and distribution utility business will continue to be called Exelon and trade on Nasdaq under the ticker symbol "EXC." Constellation has begun “regular way” trading on the Nasdaq Global Select Market today under the symbol “CEG.”

Douglas Elliman Inc. 11/08/2021 VGR
Vector Group Ltd, spinoff details:

November 08, 2021: Vector Group Ltd. (VGR) announced that Douglas Elliman Inc. plans to file a Form 10 registration statement with the United States Securities and Exchange Commission in connection with its intended spin-off into a standalone, publicly-traded company.

Investor presentation

November 10, 2021: Form 10-12B

December 10, 2021: Vector Group Ltd. (VGR) announced that its board of directors has approved the spin-off of Douglas Elliman Inc.  which is expected to be completed in late-December.

December 30, 2021: Vector Group Ltd. (VGR) has completed the spin-off of Douglas Elliman Inc. into a standalone, publicly traded company. Douglas Elliman’s common stock will begin “regular way” trading on the New York Stock Exchange on December 30, 2021 under the symbol “DOUG” and Vector Group will continue to trade on the NYSE under the symbol “VGR”.

Premium member can access all Completed Spinoffs. Subscribe today.